Asenapine versus olanzapine in patients with predominant, persistent negative symptoms of schizophrenia

被引：0
|
作者：
Cazorla, P. [1 ]
Panagides, J. [2 ]
Alphs, L.
Kouassi, A.
Buchanan, R. [3 ]
Szegedi, A.
机构：
[1] Schering Plough Corp, Organon, Roseland, NJ USA
[2] Organon Int BV, Clin Dev Asenapine, Roseland, NJ USA
[3] Univ Maryland, Baltimore, MD 21201 USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2008年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：138 / 139
页数：2
相关论文
共 50 条
  • [1] Asenapine Versus Olanzapine in People With Persistent Negative Symptoms of Schizophrenia
    Buchanan, Robert W.
    Panagides, John
    Zhao, Jun
    Phiri, Phillip
    den Hollander, Wil
    Ha, Xianwei
    Kouassi, Alex
    Alphs, Larry
    Schooler, Nina
    Szegedi, Armin
    Cazorla, Pilar
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (01) : 36 - 45
  • [2] Asenapine versus Olanzapine in People with Persistent Negative Symptoms of Schizophrenia (vol 32, pg 36, 2012)
    Buchanan, R. W.
    Panagides, J.
    Zhao, J.
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (05) : 523 - 523
  • [3] Long-term effects of asenapine or olanzapine in patients with persistent negative symptoms of schizophrenia: A pooled analysis
    Potkin, Steven G.
    Phiri, Phillip
    Szegedi, Armin
    Zhao, Jun
    Alphs, Larry
    Cazorla, Pilar
    [J]. SCHIZOPHRENIA RESEARCH, 2013, 150 (2-3) : 442 - 449
  • [4] A POOLED ANALYSIS OF THE EFFECTS OF ASENAPINE ON THE PERSISTENT NEGATIVE SYMPTOMS OF SCHIZOPHRENIA
    Potkin, S. G.
    Phiri, P.
    Zhao, J.
    Alphs, L.
    Buchanan, R. W.
    Szegedi, A.
    Panagides, J.
    Cazorla, P.
    [J]. EUROPEAN PSYCHIATRY, 2011, 26
  • [5] A pooled analysis of the effects of asenapine on the persistent negative symptoms of schizophrenia
    Potkin, S.
    Phiri, P.
    Zhao, J.
    Alphs, L.
    Buchanan, R.
    Szegedi, A.
    Panagides, J.
    Cazorla, P.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 86 - 86
  • [6] Quetiapine versus olanzapine for the treatment of negative symptoms in patients with schizophrenia
    Sirota, Pinkhas
    Pannet, Irit
    Koren, Ady
    Tchernichovsky, Eieonora
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2006, 21 (04) : 227 - 234
  • [7] The effectiveness of quetiapine versus olanzapine in improving negative symptoms of patients with schizophrenia
    Sirota, P
    Tchernichowsky, E
    Panet, I
    Koren, A
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 170 - 170
  • [8] Long-term efficacy of asenapine in people with persistent negative symptoms of schizophrenia
    Cazorla, P.
    Panagides, J.
    Zhao, J.
    Phiri, P.
    Alphs, L.
    Schooler, N.
    Szegedi, A.
    Buchanan, R. W.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 215 - 215
  • [9] PREDOMINANT NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
    Millier, A.
    Aballea, S.
    Toumi, M.
    Lancon, C.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A93 - A93
  • [10] A comparison of olanzapine versus risperidone on improvement in negative symptoms and emotional discomfort in patients with schizophrenia
    Ahmed, S
    Zhang, F
    Lindborg, S
    Tohen, M
    Breier, A
    [J]. SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 270 - 270
12345